<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="629">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>5/10/2005</approvaldate>
  <actrnumber>ACTRN12605000593639</actrnumber>
  <trial_identification>
    <studytitle>Cardiovascular and Periodontal Study: a randomised controlled trial</studytitle>
    <scientifictitle>The effect of a triclosan containing dentifrice on the relationship between periodontal disease and cardiovascular disease</scientifictitle>
    <utrn />
    <trialacronym>CAPS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Periodontal disease</healthcondition>
    <healthcondition>Cardiovascular disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients in the intervention arm will be given toothbrushing instruction at baseline and provided with a triclosan toothpaste. Both groups will be enrolled for 3-5 years and examined annually.</interventions>
    <comparator>Those in the control group will receive toothbrushing instruction at baseline and a placebo toothpaste.</comparator>
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Progression of periodontal disease in the triclosan versus placebo groups</outcome>
      <timepoint>Measured annually</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in serum lipid profiles</outcome>
      <timepoint>Measured at yearly intervals.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Inflammatory markers</outcome>
      <timepoint>Measured at yearly intervals.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anti-HSP 60 and anti Pg-GroEL antibodies and periodontal bacteria</outcome>
      <timepoint>Measured at yearly intervals.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To determine if the primary outcome is influenced by genotype.
</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Ecidence of myocardial infarction within the previous 3 years, recent events within the previous 3 years - episodes of unstable angina, admission to hospital, abnormal cardiogram. </inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Assignment to group by a dental assistant, after consent obtained, based on consecutive ID numbers. Toothpaste was packaged in identical tubes with code held by Colgate Australia until completion of data analysis.</concealment>
    <sequence>Computer generated random allocation with subjects allocated to equal sized treatment groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2000</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>500</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Oral Care Research Programme, The University of Queensland</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Colgate Palmolive Co USA</fundingname>
      <fundingaddress />
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Malcolm West, Department of Medicine, The University of Queensland</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Queensland Dental Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The Prince Charles Hospital Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Mary Cullinan</name>
      <address>Oral Care Research Programme
Oral Biology and Pathology
The University of Queensland
Brisbane QLD 4072</address>
      <phone>+61 7 33651905</phone>
      <fax>+61 7 33651109</fax>
      <email>m.cullinan@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Anne Carle</name>
      <address>Research Nurse
The Prince Charles Hospital
Level 1
Clinical Sciences Building
Rode Rd
Chermside QLD 4032</address>
      <phone>+61 7 33508300</phone>
      <fax />
      <email>carle@medicine.herston.uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>